Crossref
Terminology for biosimilars–a confusing minefield
Generics and Biosimilars Initiative Journal · 2012
DOI: 10.5639/gabij.2012.0103-4.023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Generics and Biosimilars Initiative Journal, 2012. Verfasst von Robin Thorpe. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Biosimilars are firmly established in the EU as copy biologicals with a clear and effective regulatory route for approval. Unfortunately, inconsistency in nomenclature for biosimilars has caused confusion.
Zitieren
APA
Thorpe, R. (2012). Terminology for biosimilars–a confusing minefield. Generics and Biosimilars Initiative Journal. https://doi.org/10.5639/gabij.2012.0103-4.023
Vancouver
Thorpe R. Terminology for biosimilars–a confusing minefield. Generics and Biosimilars Initiative Journal. 2012. doi:10.5639/gabij.2012.0103-4.023
BibTeX
@article{Thorpe2012,
author = {Thorpe, Robin},
title = {Terminology for biosimilars–a confusing minefield},
journal = {Generics and Biosimilars Initiative Journal},
year = {2012},
doi = {10.5639/gabij.2012.0103-4.023}
}
EUVIMED